PMID- 24350273 OWN - NLM STAT- MEDLINE DCOM- 20140811 LR - 20211021 IS - 2314-6141 (Electronic) IS - 2314-6133 (Print) VI - 2013 DP - 2013 TI - Ligand-specific regulation of the endogenous mu-opioid receptor by chronic treatment with mu-opioid peptide agonists. PG - 501086 LID - 10.1155/2013/501086 [doi] LID - 501086 AB - Since the discovery of the endomorphins (EM), the postulated endogenous peptide agonists of the mu-opioid receptors, several analogues have been synthesized to improve their binding and pharmacological profiles. We have shown previously that a new analogue, cis-1S,2R-aminocyclohexanecarboxylic acid(2)-endomorphin-2 (ACHC-EM2), had elevated mu-receptor affinity, selectivity, and proteolytic stability over the parent compound. In the present work, we have studied its antinociceptive effects and receptor regulatory processes. ACHC-EM2 displayed a somewhat higher (60%) acute antinociceptive response than the parent peptide, EM2 (45%), which peaked at 10 min after intracerebroventricular (icv) administration in the rat tail-flick test. Analgesic tolerance developed to the antinociceptive effect of ACHC-EM2 upon its repeated icv injection that was complete by a 10-day treatment. This was accompanied by attenuated coupling of mu-sites to G-proteins in subcellular fractions of rat brain. Also, the density of mu-receptors was upregulated by about 40% in the light membrane fraction, with no detectable changes in surface binding. Distinct receptor regulatory processes were noted in subcellular fractions of rat brains made tolerant by the prototypic full mu-agonist peptide, DAMGO, and its chloromethyl ketone derivative, DAMCK. These results are discussed in light of the recently discovered phenomenon, that is, the "so-called biased agonism" or "functional selectivity". FAU - Muranyi, Marianna AU - Muranyi M AD - Institute of Biochemistry, Biological Research Center, Hungarian Academy of Sciences, P.O. Box 521, Szeged 6701, Hungary. FAU - Cinar, Resat AU - Cinar R AD - Institute of Biochemistry, Biological Research Center, Hungarian Academy of Sciences, P.O. Box 521, Szeged 6701, Hungary. FAU - Kekesi, Orsolya AU - Kekesi O AD - Institute of Biochemistry, Biological Research Center, Hungarian Academy of Sciences, P.O. Box 521, Szeged 6701, Hungary. FAU - Birkas, Erika AU - Birkas E AD - Institute of Biochemistry, Biological Research Center, Hungarian Academy of Sciences, P.O. Box 521, Szeged 6701, Hungary. FAU - Fabian, Gabriella AU - Fabian G AD - Institute of Biochemistry, Biological Research Center, Hungarian Academy of Sciences, P.O. Box 521, Szeged 6701, Hungary. FAU - Bozo, Beata AU - Bozo B AD - Institute of Biochemistry, Biological Research Center, Hungarian Academy of Sciences, P.O. Box 521, Szeged 6701, Hungary. FAU - Zentai, Andras AU - Zentai A AD - Institute of Biochemistry, Biological Research Center, Hungarian Academy of Sciences, P.O. Box 521, Szeged 6701, Hungary ; Department of Pathophysiology, Faculty of Medicine, University of Szeged, Szeged, Hungary. FAU - Toth, Geza AU - Toth G AD - Institute of Biochemistry, Biological Research Center, Hungarian Academy of Sciences, P.O. Box 521, Szeged 6701, Hungary. FAU - Kicsi, Emese Gabriella AU - Kicsi EG AD - Institute of Biochemistry, Biological Research Center, Hungarian Academy of Sciences, P.O. Box 521, Szeged 6701, Hungary. FAU - Macsai, Monika AU - Macsai M AD - Department of Pathophysiology, Faculty of Medicine, University of Szeged, Szeged, Hungary. FAU - Dochnal, Roberta AU - Dochnal R AD - Department of Pathophysiology, Faculty of Medicine, University of Szeged, Szeged, Hungary. FAU - Szabo, Gyula AU - Szabo G AD - Department of Pathophysiology, Faculty of Medicine, University of Szeged, Szeged, Hungary. FAU - Szucs, Maria AU - Szucs M AD - Institute of Biochemistry, Biological Research Center, Hungarian Academy of Sciences, P.O. Box 521, Szeged 6701, Hungary. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20131124 PL - United States TA - Biomed Res Int JT - BioMed research international JID - 101600173 RN - 0 (Amino Acid Chloromethyl Ketones) RN - 0 (Analgesics) RN - 0 (Ligands) RN - 0 (Opioid Peptides) RN - 0 (Receptors, Opioid, mu) RN - 100929-53-1 (Enkephalin, Ala(2)-MePhe(4)-Gly(5)-) RN - 109377-04-0 (tyrosyl-alanyl-glycyl-N(alpha)-methylphenylalanine chloromethyl ketone) RN - EC 3.6.1.- (GTP-Binding Proteins) SB - IM MH - Amino Acid Chloromethyl Ketones/pharmacology MH - Analgesics/*pharmacology MH - Animals MH - Brain/drug effects/metabolism MH - Enkephalin, Ala(2)-MePhe(4)-Gly(5)-/pharmacology MH - GTP-Binding Proteins/metabolism MH - Ligands MH - Opioid Peptides/*metabolism MH - Pain Measurement/methods MH - Rats MH - Rats, Wistar MH - Receptors, Opioid, mu/*metabolism MH - Up-Regulation/drug effects PMC - PMC3857906 EDAT- 2013/12/19 06:00 MHDA- 2014/08/12 06:00 PMCR- 2013/11/24 CRDT- 2013/12/19 06:00 PHST- 2013/04/30 00:00 [received] PHST- 2013/08/22 00:00 [revised] PHST- 2013/09/06 00:00 [accepted] PHST- 2013/12/19 06:00 [entrez] PHST- 2013/12/19 06:00 [pubmed] PHST- 2014/08/12 06:00 [medline] PHST- 2013/11/24 00:00 [pmc-release] AID - 10.1155/2013/501086 [doi] PST - ppublish SO - Biomed Res Int. 2013;2013:501086. doi: 10.1155/2013/501086. Epub 2013 Nov 24.